Gestión Multidisciplinar de retinoblastoma: La experiencia de México.

David  Ancona Lezama; Daniela  Gómez Elizondo; Daniel Bastán Fabián; José  Figueroa Sánchez; Francisco  Rivera Ortegón; Juan Páez Garza; Leslie Thompson García; Andrea  Rangel Padilla; Sara González Godínez; Dione Aguilar Y Méndez; Rocio Villafuerte De La Cruz; Homero Sandoval Alfaro; Melissa Rodríguez Villareal; Caroline Guerrero De Ferrán; Leslie Uribe Ortiz; Erik Pérez Ramos; Cecilia Crisóstomo Aguilar

doi:10.56172/oftalmica.v20i.20

Autores/as

David Ancona Lezama
Daniela Gómez Elizondo
Daniel Bastán Fabián
José Figueroa Sánchez
Francisco Rivera Ortegón
Juan Páez Garza
Leslie Thompson García
Andrea Rangel Padilla
Sara González Godínez
Dione Aguilar Y Méndez
Rocio Villafuerte De La Cruz
Homero Sandoval Alfaro
Melissa Rodríguez Villareal
Caroline Guerrero De Ferrán
Leslie Uribe Ortiz
Erik Pérez Ramos
Cecilia Crisóstomo Aguilar

DOI:

https://doi.org/10.56172/oftalmica.v20i.20

Palabras clave:

Ojo, Retinoblastoma, Multidisciplinar, Pediátrico, Oncología Diagnóstico, Tratamiento

Resumen

El retinoblastoma es un tumor que representa aproximadamente el 3% de los cánceres en niños menores de 15 años, siendo el 95% diagnosticado antes 5 años. Por lo general, se limita al ojo, lo que resulta en una tasa de supervivencia que oscila entre 30 - 97%, siendo superior al 97% en los países de ingresos altos (HIC).1,2 El tratamiento del retinoblastoma es complejo y requiere un enfoque multidisciplinario para lograr los objetivos principales de la supervivencia del paciente, globo ocular conservación y optimización de la función visual.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Ghisoli ML, Zage PE, Herzog C, ChevezBarrios P, Chintagumpala M, Hurwitz RL, et al. Multidisciplinary Management of Retinoblastoma: Diagnosis, Treatment, and Future Direction. Ophthalmic Oncology. 2010;:179-99. https://doi.org/10.1007/978-1-4419-0374-7_14

Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129-31 https://doi.org/10.1136/bjo.2008.150292

NCI Dictionary of Cancer Terms. National Cancer Institute. Available: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/multidisciplinary [Accessed 22 Dec 2020]

Ek U. Emotional reactions in parents and children after diagnosis and treatment of a malignant tumour in the eye. Child Care Health Dev. 2000;26:415-428. https://doi.org/10.1046/j.1365-2214.2000.00159.x

Hamama-Raz Y, Rot I, Buchbinder E. The coping experience of parents of a child with retinoblastoma-malignant eye cancer. J Psychosoc Oncol. 2012;30:21-40. https://doi.org/10.1080/07347332.2011.633977

Tröster H. Sources of stress in mothers of young children with visual impairments. J Vis Impair Blind. 2001;95:623-637. https://doi.org/10.1177/0145482X0109501005

Hile S, Erickson SK, Agee B, et al. Parental stress predicts func- tional outcome in pediatric cancer survivors. Psycho-Oncology 2014;23:1157-1164. https://doi.org/10.1002/pon.3543

Luna-Fineman S, Barnoya M, Bonilla M, Fu L, Baez F, Rodríguez-Galindo C. Retinoblastoma in Central America: Report from the Central American Association of Pediatric Hematology Oncology (AHOPCA). Pediatric Blood & Cancer. 2011;58(4):545-50. https://doi.org/10.1002/pbc.23307

Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, et al. Retinoblastoma. The Lancet. 2012;379(9824):1436-46. https://doi.org/10.1016/S0140-6736(11)61137-9

M. A. Ramirez-Ortiz, V. C. Lansingh, K. A. Eckert et al., Systematic review of the current status of programs and general knowledge of diagnosis and management of retinoblastoma. Boletın Medico del Hospital Infantil de Mexico. 2017;74(1):41- 54. https://doi.org/10.1016/j.bmhimx.2016.08.002

https://doi.org/10.1016/j.bmhime.2017.12.001

Sociedad Mexicana de Oftalmología A. C. Available: https://www.smo.org.mx/directorio_medico.php [Accessed 22 Dec 2020]

Informe sobre la Salud de los Mexicanos - Diagnóstico General del Sistema Nacional de Salud. 2016, Available: https://www.gob.mx/cms/uploads/attachment/file/239410/ISSM_2016.pdf [Accessed 22 Dec 2020]

Garza-Garza LA, Ruiz-Lozano RE, RebolledoMéndez G, Ibarra-Nava I, Morales-Garza HJ, Ancona-Lezama D. Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions. Journal of Ophthalmology. 2020;2020:1-6. https://doi.org/10.1155/2020/1953602

Quélin C, Bendavid C, Dubourg C, Rochebrochard CDL, Lucas J, Henry C, et al. Twelve new patients with 13q deletion syndrome: Genotype- phenotype analyses in progress. European Journal of Medical Genetics. 2009;52(1):41-6. https://doi.org/10.1016/j.ejmg.2008.10.002

Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer. 1994;73: 692-8.

https://doi.org/10.1002/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8

Shields CL, Schoenberg E, Kocher K, Shukla SY, Kaliki S, Shields JA. Lesions Simulating Retinoblastoma (Pseudoretinoblastoma) in 604 Cases. Ophthalmology. 2013;120(2):311-6. https://doi.org/10.1016/j.ophtha.2012.07.067

MD MBS. Morning Glory Syndrome. American Academy of Ophthalmology. 2017. Available: https://www.aao.org/disease-review/neuroophthalmology-morning-glory-syndrome [Accessed 28 Dec 2020]

Bustos-Zepeda M, Ortega-Ramírez C. Catarata Congénita. Rev Hosp Gral Dr. M Gea González. 2001;4:57-60

Wong FL, Boice JD Jr, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF Jr, Li FP. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997;278(15):1262-7. https://doi.org/10.1001/jama.278.15.1262

https://doi.org/10.1001/jama.1997.03550150066037

Ancona-Lezama D, Garza-Garza LA, RuizLozano RE, Shields CL, Villagomez-Valdez LG, De-Leija-Portilla JO. Diffuse infiltrative retinoblastoma with retinal detachment in "cinnamon-roll" configuration: a case report. J AAPOS. 2020;S1091-8531(20)30315-3.

https://doi.org/10.1016/j.jaapos.2020.10.004

Ancona-Lezama D, Dalvin LA, Shields CL. Modern treatment of retinoblastoma: A 2020 review. Indian J Ophthalmol 2020;68:2356-65. https://doi.org/10.4103/ijo.IJO_721_20

Fabian ID, Reddy A, Sagoo MS. Classification and staging of retinoblastoma. Community Eye Heal J. 2018;31(101):11-13.

Shields CL, Lally SE. 10 10.1. In: Duangnate Rojanaporn, ed. 1st ed. Springer Singapore; 2019:91-99.

https://doi.org/10.1007/978-981-13-2336-2

Fabian ID, Onadim Z, Karaa E, Duncan C, Chowdhury T, Scheimberg I, et al. The management of retinoblastoma. Oncogene [Internet]. 2018;37(12):1551-60. Available from: https://doi.org/10.1038/s41388-017-0050-x

Munier FL, Beck-Popovic M, Chantada GL, Cobrinik D, Kivelä TT, Lohmann D, et al. Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity." Prog Retin Eye Res [Internet]. 2019;73(May):100764. Available from: https://doi.org/10.1016/j.preteyeres.2019.05.005

Sarici A, Kizilkilic O, Celkan T, Gode S. Blue toe syndrome as a complication of intraarterial chemotherapy for retinoblastoma. JAMA Ophthalmol. 2013;131(6):801-802. https://doi.org/10.1001/jamaophthalmol.2013.1458

Xavier Sastre, Guillermo L. Chantada, François Doz, Matthew W. Wilson, Maria T. G. de Davila, Carlos Rodríguez-Galindo, Murali Chintagumpala, Patricia Chévez-Barrios; Proceedings of the Consensus Meetings From the International Retinoblastoma Staging Working Group on the Pathology Guidelines for the Examination of Enucleated Eyes and Evaluation of Prognostic Risk Factors in Retinoblastoma. Arch Pathol Lab Med 1 August 2009; 133 (8): 1199-1202. https://doi.org/10.5858/133.8.1199

Pulido J. Long-term visual outcome following chemoreduction for retinoblastoma: Commentary. Evidence-Based Ophthalmol. 2006;7(2):91-92. https://doi.org/10.1097/01.ieb.0000209779.95400.f6

Fabian ID, Naeem Z, Stacey AW, et al. Longterm Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes. Am J Ophthalmol. 2017;179:137-144. https://doi.org/10.1016/j.ajo.2017.05.003

Nahum MP, Gdal-On M, Kuten A, Herzl G, Horovitz Y, Arush MW Ben. Long-term followup of children with retinoblastoma. Pediatr Hematol Oncol. 2001;18(3):173-179. https://doi.org/10.1080/08880010151114769

Kamihara J, Bourdeaut F, Foulkes WD, Molenaar JJ, Mosse YP, Nakagawa A, et al. Retinoblastoma and Neuroblastoma predisposition and surveillance. Clin Cancer Res. 2017;23(13):e98-106. https://doi.org/10.1158/1078-0432.CCR-17-0652

Ford JS, Chou JF, Sklar CA, et al. Psychosocial outcomes in adult survivors of retinoblastoma. J Clin Oncol. 2015;33(31):3608-3614. https://doi.org/10.1200/JCO.2014.60.5733

Collins MLZ, Bregman J, Ford JS, Shields CL. Depression, Anxiety, and Stress in Parents of Patients With Retinoblastoma. Am J Ophthalmol. 2019;207:130-143. https://doi.org/10.1016/j.ajo.2019.05.020